About
Impact
History
Team
Careers
Blog
Media Room
What is Immunotherapy?
Immunotherapy Basics
Treatment Types
Cancer Types
Side Effects
Patient Support
Patient Resources
Clinical Trials
Immunotherapy Stories
Connect with ImmunoAdvocates
Grants & Research Programs
Apply for Grants
Research Programs
Clinical Programs
Data Programs
CRI Funded Scientists
Get Involved
Ways to give
Fundraise
Events
Partnership
Contact
Search for:
Search
Donate
Immune to Cancer: The CRI Blog
Tecelra® Receives FDA Approval: A New Milestone in Cancer Treatment
On August 2, 2024, the U.S Food and Drug Administration (FDA) approved Tecelra® (afamitresgene autoleucel), a gene…
Read More
August 15, 2024
|
Ajit Muley, PhD
